naltrexone and Cancer of Cervix

naltrexone has been researched along with Cancer of Cervix in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Adachi, N; Hiraoka, M; Ishida, M; Ishiguro, T; Itoga, T; Onishi, H; Sugano, K; Yaguchi, A	1
Chen, H; Gao, S; Hu, F; Liu, N; Ma, M; Qu, N; Shan, F; Wang, R	1

Other Studies

2 other study(ies) available for naltrexone and Cancer of Cervix

Article	Year
Naldemedine-induced opioid withdrawal syndrome with severe psychiatric symptoms in an advanced cervical cancer patient without brain metastasis. Palliative & supportive care, 2022, Volume: 20, Issue:3 Topics: Adult; Analgesics, Opioid; Brain Neoplasms; Constipation; Female; Humans; Naltrexone; Narcotic Antagonists; Uterine Cervical Neoplasms	2022
Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo. International immunopharmacology, 2020, Volume: 86 Topics: Animals; Antineoplastic Agents; Apoptosis; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytokines; Epithelial-Mesenchymal Transition; Female; Gene Knockdown Techniques; Humans; Macrophage Activation; Mice, Inbred BALB C; Mice, Nude; Naltrexone; Receptors, Opioid; Snail Family Transcription Factors; Tumor-Associated Macrophages; Uterine Cervical Neoplasms; Vimentin; Xenograft Model Antitumor Assays	2020

Article

Year

Naldemedine-induced opioid withdrawal syndrome with severe psychiatric symptoms in an advanced cervical cancer patient without brain metastasis.

Palliative & supportive care, 2022, Volume: 20, Issue:3

Topics: Adult; Analgesics, Opioid; Brain Neoplasms; Constipation; Female; Humans; Naltrexone; Narcotic Antagonists; Uterine Cervical Neoplasms

2022

Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo.

International immunopharmacology, 2020, Volume: 86

Topics: Animals; Antineoplastic Agents; Apoptosis; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytokines; Epithelial-Mesenchymal Transition; Female; Gene Knockdown Techniques; Humans; Macrophage Activation; Mice, Inbred BALB C; Mice, Nude; Naltrexone; Receptors, Opioid; Snail Family Transcription Factors; Tumor-Associated Macrophages; Uterine Cervical Neoplasms; Vimentin; Xenograft Model Antitumor Assays

2020